Corporate News 20-Jun-18
Unichem settles patent dispute for generic tadalafil (Cialis®)
Unichem Laboratories has entered into a settlement agreement with Eli Lilly & Company and ICOS Corporation to resolve their patent litigation in the United States District Court for the District of New Jersey regarding Unichem's Abbreviated New Drug Application for generic tadalafil (Cialis®). Under the settlement agreement, Unichem expects to launch its generic tadalafil product in the United States on or not before 26 March 2019 under certain circumstances
Previous News
Unichem Laboratories reports consolidated net loss of Rs 0.67 crore in the June 2023 quarter
( Results - Announcements 14-Jul-23 18:40 )
Unichem Laboratories reports consolidated net loss of Rs 44.27 crore in the March 2023 quarter
( Results - Announcements 23-May-23 14:42 )
Board of Unichem Laboratories appoints CFO
( Corporate News - 08-Aug-24 18:38 )
Unichem Laboratories reports consolidated net profit of Rs 83.99 crore in the December 2023 quarter
( Results - Announcements 05-Feb-24 14:52 )
Board of Ipca Laboratories approves acquisition of 33.38% stake in Unichem Laboratories
( Corporate News - 24-Apr-23 16:06 )
Unichem Laboratories to table results
( Corporate News - 20-May-22 16:02 )
Unichem Lab gets USFDA nod for chronic angina drug
( Hot Pursuit - 17-Mar-23 13:21 )
Unichem Laboratories to hold AGM
( Corporate News - 29-Jun-24 10:20 )
Unichem Laboratories receives USFDA approval for Guanfacine Tablets
( Corporate News - 04-Mar-21 17:30 )
Unichem Laboratories schedules board meeting
( Corporate News - 15-Jan-20 15:50 )
Unichem Labs sizzles after USFDA nod
( Hot Pursuit - 18-Nov-19 09:15 )
Other Stories
Adani Ports records 14% growth in cargo volumes in September 2024
03-Oct-24 09:37
SignatureGlobal India launches new project in Gurugram
03-Oct-24 09:34
Biocon Biologics refinances debt through USD bonds and syndicated term loan
03-Oct-24 09:29
RattanIndia Enterprises launches woman's ethnic wear brand 'Kaari'
03-Oct-24 09:26
Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets
03-Oct-24 09:23
Transformers & Rectifiers India wins order of Rs 565 cr
03-Oct-24 09:07
Tata Motors records 12% decline in Q2 sales
01-Oct-24 18:04
Tata Motors records 15% decline in September sales
01-Oct-24 17:55
Man Infra set to launch its highly anticipated Vile Parle project
01-Oct-24 17:48
Padam Cotton Yarns to declare Quarterly Result
01-Oct-24 17:39
Back
Top
